Integrated Advisors Network LLC Catalent, Inc. Transaction History

Integrated Advisors Network LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$72.36 - $113.1 $13,531 - $21,149	187 Added 3.85%	5,045 $365,000
Q2 2022 Aug 12, 2022	BUY	$87.2 - $114.05 $61,476 - $80,405	705 Added 16.98%	4,858 $521,000
Q1 2022 May 02, 2022	BUY	$94.19 - $124.49 $49,355 - $65,232	524 Added 14.44%	4,153 $461,000
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $119 - $139	-1 Reduced 0.03%	3,629 $465,000
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $58,296 - $76,014	534 Added 17.25%	3,630 $483,000
Q2 2021 Aug 06, 2021	BUY	$100.34 - $115.69 $53,380 - $61,547	532 Added 20.75%	3,096 $335,000
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $6,395 - $7,892	63 Added 2.52%	2,564 $270,000
Q4 2020 Feb 12, 2021	SELL	$85.88 - $105.36 $82,358 - $101,040	-959 Reduced 27.72%	2,501 $260,000
Q3 2020 Nov 09, 2020	SELL	$72.74 - $92.5 $17,021 - $21,645	-234 Reduced 6.33%	3,460 $296,000
Q2 2020 Aug 13, 2020	SELL	$48.02 - $79.04 $158,802 - $261,385	-3,307 Reduced 47.24%	3,694 $271,000
Q1 2020 May 06, 2020	SELL	$36.95 - $62.95 $184 - $314	-5 Reduced 0.07%	7,001 $364,000
Q4 2019 Feb 06, 2020	BUY	$47.06 - $56.64 $329,702 - $396,819	7,006 New	7,006 $394,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Integrated Advisors Network LLC, based on Form 13F filings with the SEC.

Stay updated on Integrated Advisors Network LLC with notifications on news.